Novel RB1-Loss Transcriptomic Signature Is Associated with Poor Clinical Outcomes across Cancer Types

Overview of attention for article published in Clinical Cancer Research, July 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (77th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 9 X users

patent: 1 patent

Readers on

mendeley: 57 Mendeley

So far, Altmetric has seen 11 X posts from 9 X users, with an upper bound of 36,014 followers.

RT @CCR_AACR: RB1-loss signature associated with poor survival across cancer types. https://t.co/44FQH0EXlA https://t.co/gEK7I1qpSv

RB1-loss signature associated with poor survival across cancer types. https://t.co/44FQH0EXlA https://t.co/gEK7I1qpSv

RT @CellworksLife: Novel RB1-Loss Transcriptomic Signature Is Associated with Poor Clinical Outcomes across Cancer Types. https://t.co/c5mP…

Novel RB1-Loss Transcriptomic Signature Is Associated with Poor Clinical Outcomes across Cancer Types. https://t.co/c5mPwGTgQD #mCRPC #ProstrateCancer

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 7 additional X posts.